Transform Wealth’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-111
Closed -$6K 213
2022
Q2
$6K Sell
111
-231
-68% -$17.2K ﹤0.01% 199
2022
Q1
$48K Hold
342
0.01% 221
2021
Q4
$59K Hold
342
0.01% 218
2021
Q3
$171K Hold
342
0.02% 218
2021
Q2
$172K Sell
342
-343
-50% -$184K 0.02% 220
2021
Q1
$347K Hold
685
0.07% 178
2020
Q4
$327K Hold
685
0.07% 177
2020
Q3
$197K Hold
685
0.03% 207
2020
Q2
$131K Hold
685
0.02% 218
2020
Q1
$85K Hold
685
0.02% 201
2019
Q4
$120K Hold
685
0.02% 223
2019
Q3
$103K Hold
685
0.02% 206
2019
Q2
$80K Hold
685
0.01% 228
2019
Q1
$115K Hold
685
0.02% 159
2018
Q4
$81K Hold
685
0.02% 178
2018
Q3
$104K Hold
685
0.02% 190
2018
Q2
$452K Hold
685
0.08% 159
2018
Q1
$699K Hold
685
0.13% 160
2017
Q4
$836K Buy
685
+216
+46% +$102K 0.15% 156
2017
Q3
$86K Hold
469
0.03% 209
2017
Q2
$73K Hold
469
0.08% 63
2017
Q1
$112K Hold
469
0.04% 207
2016
Q4
$127K Sell
469
-16
-3% -$3.81K 0.05% 210
2016
Q3
$108K Sell
485
-4
-0.8% -$1.12K 0.05% 202
2016
Q2
$189K Buy
+489
New +$534K 0.08% 204

Other funds holding AMPE

Transform Wealth's AMPE Position: Q3 2022 in Review

Transform Wealth sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q3 2022, closing a stake of 111 shares — an estimated $6K sold.

Transform Wealth first reported a position in AMPE in Q2 2016 and held it in 25 quarters. The position peaked at $836K in Q4 2017. 95 funds tracked by Wall St. Rank hold AMPE as of Q3 2022.

  • Transform Wealth reported no remaining Ampio Pharmaceuticals Inc. position as of Q3 2022 after selling out during the quarter.
  • Transform Wealth sold 111 Ampio Pharmaceuticals Inc. shares in Q3 2022, an estimated $6K.
  • Transform Wealth first reported a position in Ampio Pharmaceuticals Inc. in Q2 2016 and held it in 25 quarters.
  • Transform Wealth's Ampio Pharmaceuticals Inc. position peaked at $836K in Q4 2017.
  • 95 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q3 2022.

Based on Transform Wealth's 13F filing for Q3 2022, filed 21 Oct 2022.